Mechanical ventilation, a lifesaving intervention for patients with acute respiratory distress syndrome (ARDS), also unfortunately contributes to excessive mechanical stress and impaired lung physiological and structural integrity. We have elsewhere established the pivotal role of increased nicotinamide phosphoribosyltransferase (NAMPT) transcription and secretion as well as its direct binding to the toll-like receptor 4 (TLR4) in the progression of this devastating syndrome; however, regulation of this critical gene in ventilator-induced lung injury (VILI) is not well characterized. On the basis of an emerging role for epigenetics in enrichment of VILI and CpG sites within the NAMPT promoter and 5′UTR, we hypothesized that NAMPT expression and downstream transcriptional events are influenced by epigenetic mechanisms. Concomitantly, excessive mechanical stress of human pulmonary artery endothelial cells or lipopolysaccharide (LPS) treatment led to both reduced DNA methylation levels in the NAMPT promoter and increased gene transcription. Histone deacetylase inhibition by trichostatin A or Sirt-1-silencing RNA attenuates LPS-induced NAMPT expression. Furthermore, recombinant NAMPT administration induced TLR4-dependent global H3K9 hypoacetylation. These studies suggest a complex epigenetic regulatory network of NAMPT in VILI and ARDS and open novel strategies for combating VILI and ARDS.Keywords: lung endothelium, epigenetics, DNA methylation, epigenetic modifiers, histone acetylation. Acute respiratory distress syndrome (ARDS) is a devastating inflammatory syndrome affecting over 200,000 people a year that is associated with significantly high morbidity and mortality rates. Mechanical ventilation, a lifesaving intervention, paradoxically contributes directly to an inflammatory syndrome effectuated by excessive mechanical stress known as ventilator-induced lung injury (VILI).
2VILI is indistinguishable in pathobiology from ARDS and includes the most common features of ARDS-like hypoxemia, inflammation, and pulmonary edema and aggravates earlier insult.2 However, the mechanisms underlying the pathobiology are very poorly understood and need further evaluation. Our genomic-intensive approaches using preclinical models of ARDS and VILI identified nicotinamide phosphoribosyltransferase (NAMPT) as a novel mediator of VILI.3 NAMPT, as an intracellular molecule, is a rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD) biosynthesis, influencing the metabolism of the cell and fueling sirtuin activity. 4 NAMPT also exists as an extracellular molecule where circulating plasma levels represent a biomarker of disease as well as contribute to the development and severity of VILI as an inflammatory stimulus. 5,6 Multiple preclinical models using murine and canine models have exhibited NAMPT localization to lung leukocytes, epithelium, and the endothelium. 5 Reduced NAMPT activity through silencing, moderating the catalytic activity (neutralizing antibodies), or utilizing mice with partial NAMPT genetic dele...